Pancreatic cancer (PC) is one of the deadliest carcinomas and in most cases, which are diagnosed with locally advanced or metastatic disease, current therapeutic options are highly unsatisfactory. Based on the anti-proliferative effects shown by nitroxoline, an old urinary antibacterial agent, we explored a large library of newly synthesised derivatives to unravel the importance of the OH moiety and pyridine ring of the parent compound. The new derivatives showed a valuable anti-proliferative effect and some displayed a greater effect as compared to nitroxoline against three pancreatic cancer cell lines with different genetic profiles. In particular, in silico pharmacokinetic data, clonogenicity assays and selectivity indexes of the most promising compounds showed several advantages for such derivatives, as compared to nitroxoline. Moreover, some of these novel compounds had stronger effects on cell viability and/or clonogenic capacity in PC cells as compared to erlotinib, a targeted agent approved for PC treatment.

Synthesis and evaluation of a large library of nitroxoline derivatives as pancreatic cancer antiproliferative agents / Veschi, Serena; Carradori, Simone; De Lellis, Laura; Florio, Rosalba; Brocco, Davide; Secci, Daniela; Guglielmi, Paolo; Spano, Mattia; Sobolev, Anatoly P.; Cama, Alessandro. - In: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. - ISSN 1475-6366. - 35:1(2020), pp. 1331-1344. [10.1080/14756366.2020.1780228]

Synthesis and evaluation of a large library of nitroxoline derivatives as pancreatic cancer antiproliferative agents

Secci, Daniela;Guglielmi, Paolo;Spano, Mattia;
2020

Abstract

Pancreatic cancer (PC) is one of the deadliest carcinomas and in most cases, which are diagnosed with locally advanced or metastatic disease, current therapeutic options are highly unsatisfactory. Based on the anti-proliferative effects shown by nitroxoline, an old urinary antibacterial agent, we explored a large library of newly synthesised derivatives to unravel the importance of the OH moiety and pyridine ring of the parent compound. The new derivatives showed a valuable anti-proliferative effect and some displayed a greater effect as compared to nitroxoline against three pancreatic cancer cell lines with different genetic profiles. In particular, in silico pharmacokinetic data, clonogenicity assays and selectivity indexes of the most promising compounds showed several advantages for such derivatives, as compared to nitroxoline. Moreover, some of these novel compounds had stronger effects on cell viability and/or clonogenic capacity in PC cells as compared to erlotinib, a targeted agent approved for PC treatment.
2020
nitroxoline derivatives; drug repurposing; pancreatic cancer; erlotinib; clonogenicity; 4- nitro(thio)phenyl
01 Pubblicazione su rivista::01a Articolo in rivista
Synthesis and evaluation of a large library of nitroxoline derivatives as pancreatic cancer antiproliferative agents / Veschi, Serena; Carradori, Simone; De Lellis, Laura; Florio, Rosalba; Brocco, Davide; Secci, Daniela; Guglielmi, Paolo; Spano, Mattia; Sobolev, Anatoly P.; Cama, Alessandro. - In: JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY. - ISSN 1475-6366. - 35:1(2020), pp. 1331-1344. [10.1080/14756366.2020.1780228]
File allegati a questo prodotto
File Dimensione Formato  
Veschi_Synthesis_2020.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 2.91 MB
Formato Adobe PDF
2.91 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1439461
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 7
social impact